CAPTRUST Financial Advisors
CVAC

CAPTRUST Financial Advisors’s CureVac CVAC Stock Holding History

CAPTRUST Financial Advisors’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50
Closed -$1K – 2506
2022
Q2 		$1K Sell
50
-6
-11% -$99 ﹤0.01% 4657
2022
Q1 		$1K Sell
56
-95
-63% -$1.9K ﹤0.01% 4676
2021
Q4 		$5K Sell
151
-5
-3% -$201 ﹤0.01% 4055
2021
Q3 		$9K Buy
+156
New +$9.4K ﹤0.01% 3658

Other funds holding CVAC

GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAPTRUST Financial Advisors's CVAC Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of CureVac (CVAC) in Q3 2022, closing a stake of 50 shares — an estimated $1K sold.

CAPTRUST Financial Advisors first reported a position in CVAC in Q3 2021 and held it in 4 quarters. The position peaked at $9K in Q3 2021. 83 funds tracked by Wall St. Rank hold CVAC as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining CureVac position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 50 CureVac shares in Q3 2022, an estimated $1K.
  • CAPTRUST Financial Advisors first reported a position in CureVac in Q3 2021 and held it in 4 quarters.
  • CAPTRUST Financial Advisors's CureVac position peaked at $9K in Q3 2021.
  • 83 funds tracked by Wall St. Rank held CureVac as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.